The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
rhBMP-2 release from injectable poly (DL-lactic-co-glycolic acid)/calcium-phosphate cement composites
Abstract
BACKGROUND: In bone tissue engineering, poly(DL-lactic-co-glycolic acid) (PLGA) microparticles are frequently used as a delivery vehicle for bioactive molecules. Calcium phosphate cement is an injectable, osteoconductive, and degradable bone cement that sets in situ. The objective of this study was to create an injectable composite based on calcium phosphate cement embedded with PLGA microparticles for sustained delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2). METHODS: (125) I-labeled rhBMP-2 was incorporated in PLGA microparticles. PLGA microparticle/calcium-phosphate cement composites were prepared in a ratio of 30:70 by weight. Material properties were evaluated by scanning electron microscopy, microcomputed tomography, and mechanical testing. Release kinetics of rhBMP-2 from PLGA/calcium-phosphate cement disks and PLGA microparticles alone were determined in vitro in two buffer solutions (pH 7.4 and pH 4.0) for up to twenty-eight days. RESULTS: The entrapment yield of rhBMP-2 in PLGA microparticles was a mean (and standard deviation) of 79% +/- 8%. Analysis showed spherical PLGA microparticles (average size, 17.2 +/-1.3 micro m) distributed homogeneously throughout the nanoporous disks. The average compressive strength was significantly lower (p < 0.001) for PLGA and calcium-phosphate cement composite scaffolds than for calcium-phosphate cement scaffolds alone (6.4 +/- 0.6 MPa compared with 38.6 +/- 2.6 MPa, respectively). Average rhBMP-2 loading was 5.0 +/- 0.4 micro g per 75-mm (3) disk. Release of rhBMP-2 was limited for all formulations. At pH 7.4, 3.1% +/- 0.1% of the rhBMP-2 was released from the PLGA/calcium-phosphate cement disks and 18.0% +/- 1.9% was released from the PLGA microparticles alone after twenty-eight days. At pH 4.0, PLGA/calcium-phosphate cement disks revealed more release of rhBMP-2 than did PLGA microparticles alone (14.5% +/- 6.3% compared with 5.4% +/- 0.7%) by day 28. CONCLUSIONS: These results indicate that preparation of a PLGA/calcium-phosphate cement composite for the delivery of rhBMP-2 is feasible and that the release of rhBMP-2 is dependent on the composite composition and nanostructure as well as the pH of the release medium.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PLGA are a family of FDA-approved biodegradable polymers that are physically strong and highly biocompatible and have been extensively studied as delivery vehicles for drugs, proteins and various other macromolecules such as DNA, RNA and peptides [1–3].”
From Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier (2011) · cites this paper as [3]
In the citing paper
“PLGA are a family of FDA-approved biodegradable polymers that are physically strong and highly biocompatible and have been extensively studied as delivery vehicles for drugs, proteins and various other macromolecules such as DNA, RNA and peptides [1–3].”
From Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier (2011) · cites this paper as [3]
In the citing paper
“PLGA are a family of FDA-approved biodegradable polymers that are physically strong and highly biocompatible and have been extensively studied as delivery vehicles for drugs, proteins and various other macromolecules such as DNA, RNA and peptides [1–3].”
From Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier (2011) · cites this paper as [3]
In the citing paper
“PLGA are a family of FDA-approved biodegradable polymers that are physically strong and highly biocompatible and have been extensively studied as delivery vehicles for drugs, proteins and various other macromolecules such as DNA, RNA and peptides [1–3].”
From Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier (2011) · cites this paper as [3]
In the citing paper
“PLGA are a family of FDA-approved biodegradable polymers that are physically strong and highly biocompatible and have been extensively studied as delivery vehicles for drugs, proteins and various other macromolecules such as DNA, RNA and peptides [1–3].”
From Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier (2011) · cites this paper as [3]
Citations
Cites
Cook, A. D., Hrkach, J. S., Gao, N. N., Johnson, I. M., Pajvani, U. B., Cannizzaro, S. M., & Langer, R. (1997) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(19970615)35:4<473::aid-jbm7>3.0.co;2-e · Cited by 319
Self-citationA new method to produce macropores in calcium phosphate cements
del Real, R. P., Wolke, J. G. C., Vallet-Regı́, M., & Jansen, J. A. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00101-1 · Cited by 265
Self-citationControlled release of transforming growth factor ?1 from biodegradable polymer microparticles
Lu, L., Stamatas, G. N., & Mikos, A. G. (2000) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(20000605)50:3<440::aid-jbm19>3.0.co;2-g · Cited by 170
Self-citationPéan, J.-M., Venier-Julienne, M.-C., Boury, F., Menei, P., Denizot, B., & Benoit, J.-P. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00086-8 · Cited by 166
Woo, B. H., Fink, B. F., Page, R., Schrier, J. A., Jo, Y. W., Jiang, G., DeLuca, M., Vasconez, H. C., & DeLuca, P. P. (2001) · Pharmaceutical Research · doi:10.1023/a:1013382832091 · Cited by 165
Peter, S. J., Lu, L., Kim, D., Stamatas, G. N., Miller, M. J., Yaszemski, M. J., & Mikos, A. G. (2000) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(20000605)50:3<452::aid-jbm20>3.0.co;2-0 · Cited by 125
Self-citationControlled release of an osteogenic peptide from injectable biodegradable polymeric composites
Hedberg, E. L., Tang, A., Crowther, R. S., Carney, D. H., & Mikos, A. G. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00261-4 · Cited by 117
Self-citationBiological Activity of rhBMP-2 Released From PLGA Microspheres
Oldham, J. B., Lu, L., Zhu, A. X., Porter, B. D., Hefferan, T. E., Larson, D., Currier, B. L., Mikos, A. G., & Yaszemski, M. J. (2000) · Journal of Biomechanical Engineering · doi:10.1115/1.429662 · Cited by 99
Self-citationThe Ca/P range of nanoapatitic calcium phosphate cements
Driessens, F. C. M., Boltong, M. G., Maeyer, E. A. P. D., Wenz, R., Nies, B. A., & Planell, J. A. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00151-5 · Cited by 89
Healing of segmental bone defects in rats induced by a ?-TCP-MCPM cement combined with rhBMP-2
Ohura, K., Hamanishi, C., Tanaka, S., & Matsuda, N. (1999) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199902)44:2<168::aid-jbm7>3.0.co;2-4 · Cited by 77
Research works printed but not linked: 2
- 2003, J Biomed Mater Res, 65, 30
- 1999, J Biomed Mater Res, 46, 193, 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1 · doi:10.1002/(sici)1097-4636(199908)46:2<193::aid-jbm8>3.0.co;2-1
Cited by
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
“PLGA are a family of FDA-approved biodegradable polymers that are physically strong and highly biocompatible and have been extensively studied as delivery vehicles for drugs, proteins and various other macromolecules such as DNA, RNA and peptides [1–3].”
BackgroundElectrospun silk-BMP-2 scaffolds for bone tissue engineering
Li, C., Vepari, C., Jin, H.-J., Kim, H. J., & Kaplan, D. L. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.01.022 · Cited by 1,140
Bioactive calcium phosphate materials and applications in bone regeneration
Jeong, J., Kim, J. H., Shim, J. H., Hwang, N. S., & Heo, C. Y. (2019) · Biomaterials Research · doi:10.1186/s40824-018-0149-3 · Cited by 1,054
Bose, S., & Tarafder, S. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.11.017 · Cited by 958
Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering
Lee, S.-H., & Shin, H. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.016 · Cited by 706
Metadata
- Authors
- RUHE, Q. P., HEDBERG, E. L., PADRON, N. T., SPAUWEN, P. H. M., JANSEN, J. A., & MIKOS, A. G.
- Affiliations
- Rice University (US)
- Venue
- The Journal of Bone and Joint Surgery-American Volume
- Published
- 2003
- Volume
- 85
- Pages
- 75-81
- ISSN
- 0021-9355 (ISSN-L)
- OpenAlex
- W1865915382
- Cited by
- 186
- References
- 18
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 8 · 2019: 9 · 2018: 3 · 2017: 8 · 2016: 9 · 2015: 10 · 2014: 3 · 2013: 10 · 2012: 8
- FWCI
- 7.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Bone and Joint Surgery (publishedVersion)
- PubMed (publishedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01-AR42639, R01AR042639)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Keywords
- rhBMP-2, PLGA microspheres, calcium phosphate cement, injectable bone cement, sustained drug release, controlled release, bone tissue engineering, drug delivery, compressive strength, pH-dependent release, encapsulation efficiency, biodegradable scaffolds, bone regeneration, osteoconduction, osteoinduction
- MeSH terms
- Polylactic Acid-Polyglycolic Acid Copolymer, Bone Cements, Calcium Phosphates, Drug Carriers, Glycolates, Humans, Injections, Microscopy, Electron, Scanning, Particle Size, Polyglycolic Acid, Recombinant Proteins, Transforming Growth Factor beta, Lactic Acid, Bone Morphogenetic Proteins, Bone Morphogenetic Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: rhBMP-2 release from injectable poly (DL-lactic-co-glycolic acid)/calcium-phosphate cement composites. https://app.cochat.ai/papers/10.2106/00004623-200300003-00013
- The paper
- RUHE, Q. P., HEDBERG, E. L., PADRON, N. T., SPAUWEN, P. H. M., JANSEN, J. A., & MIKOS, A. G. (2003). rhBMP-2 release from injectable poly (DL-lactic-co-glycolic acid)/calcium-phosphate cement composites. The Journal of Bone and Joint Surgery-American Volume. https://doi.org/10.2106/00004623-200300003-00013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.